Pioglitazone N-oxide

CAS : 145350-09-0

Ref. 3D-FP27056

Informations sur le produit

• Nom: Pioglitazone N-oxide
• Synonymes: 5-[[4-[2-(5-Ethyl-2-pyridinyl]ethoxy]phenyl]methyl]-2,4-thiazolidinedione N-oxide, Pioglitazone HCl, 5-[[4-[2-(5-Ethyl-2-pyridinyl]ethoxy]phenyl]methyl]-2,4-thiazolidinedione N-Oxide, Pioglitazone N-Oxide, 5-{4-[2-(5-Ethyl-1-Oxidopyridin-2-Yl)Ethoxy]Benzyl}-1,3-Thiazolidine-2,4-Dione, 5-[[4-2-(5-ethyl-2-pyridinyl)ethoxy]benzylidene]-2,4-thiazolidinedione Hydrochloride, [5-[[4-[2-(5-Ethyl-2-Pyridinyl)Ethoxy]Phenyl]Methyl]-2,4-] Thiazolidinedione Hydrochloride

Description

Pioglitazone N-oxide is a section of the drug pioglitazone, which is an oral anti-diabetic medication. Pioglitazone N-oxide has been shown to be active against typhimurium and virulent strains of bacteria. Pioglitazone N-oxide also has acidic properties that enable it to function as an antigen in immunological reactions. This drug substance is prepared by high-performance liquid chromatography (HPLC) and purified by preparative HPLC. Pioglitazone N-oxide can be used for the treatment of inflammatory diseases such as rheumatoid arthritis and Crohn's disease. The cancer cell growth inhibitory effects of pioglitazone N-oxide have been shown in animal models. It also inhibits the growth factor activity, which may contribute to its anticancer effects.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 372.44 g/mol
• Formule: C₁₉H₂₀N₂O₄S
• Degré de pureté: Min. 95%